![]() ![]() American Journal of Medicine, 120, 165–171. The association of methamphetamine use and cardiomyopathy in young patients. Clinical characteristics and outcomes of patients with amphetamine-associated cardiomyopathy in South Auckland, New Zealand. S., Lund, M., Sutton, T., Bradley, J., Kerr, A. Methamphetamine-associated cardiomyopathy: Patterns and predictors of recovery. International Journal of Cardiology, 68, e158–e160. Basal stress cardiomyopathy induced by exogenous catecholamines in younger adults. Journal of Emergency Medicine, 45, 821–827.įulcher, J., & Wilcox, I. Cardiac complications of adult methamphetamine exposures. J., Decker, L., Hurst, N., Beer, W., et al. Report of methamphetamine use and cardiomyopathy in three patients. Sadeghi, R., Agin, K., Taherkhani, M., Najm-Afshar, L., & Nelson, L. American Journal of Forensic Medicine and Pathology, 27, 156–160. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications. Crystal methamphetamine-associated cardiomyopathy: Tip of the iceberg? Journal of Toxicology-Clinical Toxicology, 41, 981–986. Wijetunga, M., Seto, T., Lindsay, J., & Schatz, I. Annals of Internal Medicine, 97, 560–561. Propylhexedrine-induced left ventricular dysfunction. Forensic Science International, 212, e1–e4.Ĭroft, C. The unique histology of methamphetamine cardiomyopathy: A case report. Methamphetamine-associated acute left ventricular dysfunction: A variant of stress-induced cardiomyopathy. Reversible dilated cardiomyopathy induced by methamphetamine. Acute amphetamine cardiomyopathy in a drug addict. Annals of Internal Medicine, 97, 559–560. Acute cardiomyopathy secondary to intravenous amphetamine use. Cardiomyopathy associated with amphetamine administration. Drug and Alcohol Dependence, 159, 181–189. Delayed emergence of methamphetamine’s enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. K., McIlwain, E., Charalampidis, D., Lucchesi, P. Chinese Medical Sciences Journal, 23, 239–243. Myocardial lesions after long-term administration of methamphetamine in rats. The prevalence and presentation of methamphetamine associated cardiomyopathy: A single Center Experience. G., Ambrose, J., Khatri, B., Bhullar, M., Nalbandyan, M., & Ronaghi, R. ![]() Methamphetamine-associated congestive heart failure: Increasing prevalence and relationship of clinical outcomes to continued use or abstinence. Methamphetamine use among pregnant women. National Drug Threat Assessment 2011, Pennsylvania. US Department of Justice National Drug Intelligence Center. United Nations Office on Drugs and Crime. Journal of the History of Medicine and Allied Sciences, 61, 288–323. ![]() Making the first anti-depressant: Amphetamine in American medicine, 1929–1950. Journal of Pharmacology and Experimental Therapeutics, 47, 339–354. The comparative physiological actions of dl-β-phenylisopropylamine. Overall, cessation of ATS exposure seems to be associated with some degree of reversibility and recovery in ATSAC sufferers.Īlles, G. Female ATS users predominantly develop Takotsubo type of ATSAC and in particular its atypical basal variant. Majority of patients with ATSAC were found to be male, young and presented late with severe dilated cardiomyopathy. Oxidative stress, accelerated apoptosis, increased p53 activity, cardiomyocyte necrosis, perfusion defects, fatty acid toxicity, altered gene expression, abnormal cardiac protein synthesis and function in addition to defects in intracellular calcium hemostasis present themselves as likely mechanisms of cardiotoxicity in ATSAC. Several animal studies, case reports, case series and case-control studies support the association between ATS exposure and ATSAC. A comprehensive systematic review was performed to explore and analyze the current evidence on the association between ATS exposure and development of cardiomyopathy, biological mechanisms involved in pathogenesis of ATSAC, risk factors, clinical features and course of patients with ATSAC. With rapidly rising prevalence of exposure to Amphetamine Type Stimulants (ATS), novel insights into cardiotoxic effects of this substance are being presented in the literature and remarkably ATS Associated Cardiomyopathy (ATSAC) is emerging as a novel cardiovascular condition with its distinctive pathogenesis, risk factors, clinical features and prognosis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |